Related Experiment Video
Updated: Jul 20, 2025

Co-culture Models of Pseudomonas aeruginosa Biofilms Grown on Live Human Airway Cells
Published on: October 6, 2010
Pseudomonas aeruginosa type IV pili actively induce mucus contraction to form biofilms in tissue-engineered human
Tamara Rossy1,2, Tania Distler1,2, Lucas A Meirelles1,2
1Global Health Institute, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Abstract:
The opportunistic pathogen Pseudomonas aeruginosa causes antibiotic-recalcitrant pneumonia by forming biofilms in the respiratory tract. Despite extensive in vitro experimentation, how P. aeruginosa forms biofilms at the airway mucosa is unresolved. To investigate the process of biofilm formation in realistic conditions, we developed AirGels: 3D, optically accessible tissue-engineered human lung models that emulate the airway mucosal environment. AirGels recapitulate important factors that mediate host-pathogen interactions including mucus secretion, flow and air-liquid interface (ALI), while accommodating high-resolution live microscopy. With AirGels, we investigated the contributions of mucus to P. aeruginosa biofilm biogenesis in in vivo-like conditions. We found that P. aeruginosa forms mucus-associated biofilms within hours by contracting luminal mucus early during colonization. Mucus contractions facilitate aggregation, thereby nucleating biofilms. We show that P. aeruginosa actively contracts mucus using retractile filaments called type IV pili. Our results therefore suggest that, while protecting epithelia, mucus constitutes a breeding ground for biofilms.
Insights
Pseudomonas aeruginosa forms biofilms in the lungs by contracting mucus with type IV pili. This mucus contraction aids bacterial aggregation, leading to rapid biofilm development in airway infections.
Area of Science:
- Microbiology
- Biomedical Engineering
- Respiratory Medicine
Background:
- Pseudomonas aeruginosa causes difficult-to-treat pneumonia by forming biofilms in the respiratory tract.
- Understanding P. aeruginosa biofilm formation at the airway mucosa is crucial but remains unresolved.
- Existing in vitro models do not fully replicate the complex airway mucosal environment.
Purpose of the Study:
- To investigate P. aeruginosa biofilm formation under realistic airway mucosal conditions.
- To elucidate the role of mucus in P. aeruginosa biofilm development.
- To explore the mechanisms by which P. aeruginosa interacts with airway mucus.
Main Methods:
- Development of AirGels: 3D, optically accessible, tissue-engineered human lung models.
- AirGels emulate airway mucosal environment: mucus secretion, flow, and air-liquid interface (ALI).
- High-resolution live microscopy to observe P. aeruginosa-mucus interactions.
Main Results:
- P. aeruginosa rapidly forms mucus-associated biofilms within hours.
- Biofilm formation is initiated by the contraction of luminal mucus.
- P. aeruginosa actively contracts mucus using type IV pili, facilitating bacterial aggregation and biofilm nucleation.
Conclusions:
- Mucus, while protective, serves as a crucial niche for P. aeruginosa biofilm formation.
- Type IV pili-mediated mucus contraction is a key mechanism in early biofilm development.
- AirGels provide a valuable model for studying host-pathogen interactions in the airway.
More Related Videos
05:03Visualizing the Effects of Sputum on Biofilm Development Using a Chambered Coverglass Model
Published on: December 14, 2016
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
Related Concept Videos
Fimbriae, Pili, and Axial Filaments
Biofilms
Gene Regulation in Microbial Communities: Quorum Sensing